Clinical Trial Update: Ipilimumab With or Without Vaccine Therapy in Treating Patients With Previously Treated Stage IV Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating ipilimumab with or without vaccine therapy for previously treated stage IV melanoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Yervoy (ipilimumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Melanoma (Skin) | Phase 2 | Status: WITHDRAWN